Biotechne revenue
WebApr 14, 2024 · The company had revenue of $271.58 million for the quarter, compared to analysts' expectations of $289.98 million. Bio-Techne had a return on equity of 15.87% … WebSep 30, 2024 · Bio-Techne's revenue growth from 2010 to 2024 is 310.93%. Bio-Techne has 2,250 employees, and the revenue per employee ratio is $491,377. Bio-Techne's …
Biotechne revenue
Did you know?
WebApr 14, 2024 · The business had revenue of $271.58 million during the quarter, compared to the consensus estimate of $289.98 million. On average, equities research analysts … WebBusiness unit leader with a record of delivering revenue growth and innovative research tools in the life sciences industry. My passion lies in developing and commercializing …
WebBio-Techne's main competitors include MilliporeSigma, Abcam, BioLegend, PeproTech, Merck Millipore and Cytiva. Compare Bio-Techne to its competitors by revenue, employee growth and other metrics at Craft. WebApr 20, 2016 · Bio-Techne's revenue is $1.1 Billion What is Bio-Techne's SIC code? Bio-Techne's SIC: 28,283 What is Bio-Techne's NAICS code? Bio-Techne's NAICS: 54,541 …
WebAccording to Bio-Techne's latest financial reports the company's current revenue (TTM) is $1.11 B. In 2024 the company made a revenue of $1.02 B an increase over the years … WebNov 2, 2024 · First Quarter FY2024 Snapshot. First quarter organic revenue increased by 21% (26% reported) to $257.7 million. GAAP EPS was $1.69 versus $0.83 one year ago. Delivered adjusted earnings per share ...
WebFeb 1, 2024 · Second quarter year-over-year organic growth for the segment was 7 percent, with acquisitions contributing 16 percent to revenue growth. Bio-Techne posted Q2 …
WebAug 5, 2024 · Revenue. Net sales for the full year fiscal 2024 increased 26% to $931.0 million. Organic growth was 22%, with foreign currency translation and acquisitions having a favorable impact of 3% and 1%, respectively. Organic revenue growth was broad based … Bio-Techne's Mission is to build Epic Tools for Epic Science. We have a creative, … Learn about our life science & clinical diagnostic brands including R&D … Financial Results - Bio-Techne Releases Fourth Quarter Fiscal 2024 Results :: … Annual Reports - Bio-Techne Releases Fourth Quarter Fiscal 2024 Results :: … Presentations - Bio-Techne Releases Fourth Quarter Fiscal 2024 Results :: … Peter Breloer joined Bio-Techne on August 1, 2015 as Vice President of Asia-Pacific … Business Description. Bio-Techne Corporation (NASDAQ: TECH) is a … Get support from our customer support, technical service, and instrument teams. … IR Calendar - Bio-Techne Releases Fourth Quarter Fiscal 2024 Results :: Bio … In the 1990s, R&D Systems turned its focus to expanding its sales and distribution … how a fox soundsWebFeb 2, 2024 · Analysts expected revenue of $206.5 million, for the quarter. Bio-Techne Corporation said its Board of Directors has decided to pay a dividend of $0.32 per share … how a free market economy operateshow many hospitals are in connecticutWebAug 4, 2024 · Revenue. Net sales for the fourth quarter increased 11% to $288.2 million. Organic growth was 14% compared to the prior year with foreign currency exchange … how a fractionating column worksWebBio-Techne's Mission is to build Epic Tools for Epic Science. We have a creative, caring team of colleagues throughout the world who bring unique perspectives and talents in support of that Mission and who embody our … how many hospitals are in ethiopiaWebApr 11, 2024 · The business had revenue of $271.58 million during the quarter, compared to analysts’ expectations of $289.98 million. Bio-Techne had a return on equity of 15.87% and a net margin of 23.38%. how a freak accident happensWebFeb 7, 2024 · Biotechne Corp (TECH) SEC Filing 10-Q Quarterly Report for the period ending Saturday, December 31, 2024. Home. SEC Filings. Biotechne Corp (TECH) 10-Q Quarterly Report Tue Feb 07 2024; SEC Filings. TECH Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. Manager Portfolios. how a four way switch works